Literature DB >> 22554256

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.

Z Permutt1, T-A Le, M R Peterson, E Seki, D A Brenner, C Sirlin, R Loomba.   

Abstract

BACKGROUND: Conventional magnetic resonance imaging (MRI) techniques that measure hepatic steatosis are limited by T1 bias, T(2)* decay and multi-frequency signal-interference effects of protons in fat. Newer MR techniques such as the proton density-fat fraction (PDFF) that correct for these factors have not been specifically compared to liver biopsy in adult patients with non-alcoholic fatty liver disease (NAFLD). AIM: To examine the association between MRI-determined PDFF and histology-determined steatosis grade, and their association with fibrosis.
METHODS: A total of 51 adult patients with biopsy-confirmed NAFLD underwent metabolic-biochemical profiling, MRI-determined PDFF measurement of hepatic steatosis and liver biopsy assessment according to NASH-CRN histological scoring system.
RESULTS: The average MRI-determined PDFF increased significantly with increasing histology-determined steatosis grade: 8.9% at grade-1, 16.3% at grade-2, and 25.0% at grade-3 with P ≤ 0.0001 (correlation: r(2) = 0.56, P < 0.0001). Patients with stage-4 fibrosis, when compared with patients with stage 0-3 fibrosis, had significantly lower hepatic steatosis by both MRI-determined PDFF (7.6% vs. 17.8%, P < 0.005) and histology-determined steatosis grade (1.4 vs. 2.2, P < 0.05). NAFLD patients with grade 1 steatosis were more likely to have characteristics of advanced liver disease including higher average AST:ALT (0.87 vs. 0.60, P < 0.02), GGT (140 vs. 67, P < 0.01), and INR (1.06 vs. 0.99, P < 0.01), higher stage of fibrosis and hepatocellular ballooning.
CONCLUSIONS: MRI-determined proton density-fat fraction correlates with histology-determined steatosis grade in adults with NAFLD. Steatosis is non-linearly related to fibrosis progression. In patients with NAFLD, a low amount of hepatic steatosis on imaging does not necessarily indicate mild disease.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22554256      PMCID: PMC3437221          DOI: 10.1111/j.1365-2036.2012.05121.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  24 in total

Review 1.  Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.

Authors:  G Vernon; A Baranova; Z M Younossi
Journal:  Aliment Pharmacol Ther       Date:  2011-05-30       Impact factor: 8.171

2.  T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis.

Authors:  Catherine D G Hines; Alex Frydrychowicz; Gavin Hamilton; Dana L Tudorascu; Karl K Vigen; Huanzhou Yu; Charles A McKenzie; Claude B Sirlin; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

3.  Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Authors:  Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

4.  T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Michele Di Martino; Carlo Catalano; Valeria Panebianco; Mario Bezzi; Caterina Anania; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

5.  Constraining the initial phase in water-fat separation.

Authors:  Mark Bydder; Takeshi Yokoo; Huanzhou Yu; Michael Carl; Scott B Reeder; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2010-12-14       Impact factor: 2.546

6.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T.

Authors:  Takeshi Yokoo; Masoud Shiehmorteza; Gavin Hamilton; Tanya Wolfson; Michael E Schroeder; Michael S Middleton; Mark Bydder; Anthony C Gamst; Yuko Kono; Alexander Kuo; Heather M Patton; Santiago Horgan; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2011-01-06       Impact factor: 11.105

7.  Assessment of liver fat quantification in the presence of iron.

Authors:  Mark Bydder; Masoud Shiehmorteza; Takeshi Yokoo; Sebastian Sugay; Michael S Middleton; Olivier Girard; Michael E Schroeder; Tanya Wolfson; Anthony Gamst; Claude Sirlin
Journal:  Magn Reson Imaging       Date:  2010-04-21       Impact factor: 2.546

8.  Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.

Authors:  Sina Meisamy; Catherine D G Hines; Gavin Hamilton; Claude B Sirlin; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

9.  The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

Authors:  Neeraj Bhala; Paul Angulo; David van der Poorten; Eric Lee; Jason M Hui; Giorgio Saracco; Leon A Adams; Phunchai Charatcharoenwitthaya; Joanne H Topping; Elisabetta Bugianesi; Christopher P Day; Jacob George
Journal:  Hepatology       Date:  2011-08-09       Impact factor: 17.425

10.  Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.

Authors:  Thuy-Anh Le; Joshua Chen; Christopher Changchien; Michael R Peterson; Yuko Kono; Heather Patton; Benjamin L Cohen; David Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

View more
  136 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

2.  Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.

Authors:  Ling Yang; Yoon Seok Roh; Jingyi Song; Bi Zhang; Cheng Liu; Rohit Loomba; Ekihiro Seki
Journal:  Hepatology       Date:  2013-12-18       Impact factor: 17.425

3.  Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.

Authors:  J Cui; B Ang; W Haufe; C Hernandez; E C Verna; C B Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2015-04-15       Impact factor: 8.171

4.  Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.

Authors:  Cyrielle Caussy; Cynthia Hsu; Seema Singh; Shirin Bassirian; James Kolar; Claire Faulkner; Nikhil Sinha; Ricki Bettencourt; Naveen Gara; Mark A Valasek; Bernd Schnabl; Lisa Richards; David A Brenner; Alan F Hofmann; Rohit Loomba
Journal:  Aliment Pharmacol Ther       Date:  2018-12-02       Impact factor: 8.171

5.  NAFLD: MRI versus biopsy to assess NAFLD.

Authors:  Claire Greenhill
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

6.  Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Authors:  Ken Liu; Vincent Wai-Sun Wong; Keith Lau; Sienna Du Liu; Yee-Kit Tse; Terry Cheuk-Fung Yip; Raymond Kwok; Alex Yiu-Wa Chan; Henry Lik-Yuen Chan; Grace Lai-Hung Wong
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

7.  Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.

Authors:  Charlie C Park; Catherine Hooker; Jonathan C Hooker; Emily Bass; William Haufe; Alexandra Schlein; Yesenia Covarrubias; Elhamy Heba; Mark Bydder; Tanya Wolfson; Anthony Gamst; Rohit Loomba; Jeffrey Schwimmer; Diego Hernando; Scott B Reeder; Michael Middleton; Claude B Sirlin; Gavin Hamilton
Journal:  J Magn Reson Imaging       Date:  2018-04-29       Impact factor: 4.813

8.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

9.  Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.

Authors:  N S Patel; M R Peterson; D A Brenner; E Heba; C Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2013-02-05       Impact factor: 8.171

10.  Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique.

Authors:  Christoph Mahlke; Diego Hernando; Christina Jahn; Antonio Cigliano; Till Ittermann; Anne Mössler; Marie-Luise Kromrey; Grazyna Domaska; Scott B Reeder; Jens-Peter Kühn
Journal:  J Magn Reson Imaging       Date:  2016-05-19       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.